Mitochondria is a systematic options trading firm. We treat every position like an energy transaction — measured, rules-based, and built to compound, not to gamble.
Our strategies are systematic index-options frameworks — entries, exits, and position sizing are defined in advance and executed without in-the-moment judgment calls. Every rule is written down before it ever touches live capital.
Before anything runs live, it's stress-tested across years of historical data, across both trending and rangebound regimes, and across the full CE/PE spectrum — not just the conditions where it happens to look good.
Every change to a strategy is versioned and logged as a distinct iteration, with a full report attached — what changed, why, and how it performed. Nothing is tuned quietly. If a parameter moves, there's a paper trail explaining why.
Capital preservation sits above return-chasing. Position sizing and drawdown limits are enforced mechanically, not adjusted in hindsight because a trade "felt right."
"A mitochondrion doesn't predict when energy will be needed. It just stays ready to convert it, every time, without exception." — Working principle, v0.1
Sample output from an internal strategy iteration. Shown for transparency about our process, not as a promise of what any investor will earn.
Channels — ● return ● efficiency ● risk-adjusted ● drawdown
These figures are backtested results from a single strategy configuration over a defined historical window (2025-07-17 to 2026-06-09, roughly 10.7 months). Because this period is shorter than a year, we're showing the actual cumulative return over that window rather than an annualized figure — annualizing a short, high-return backtest into a CAGR would produce a misleadingly large number that assumes performance repeats indefinitely. Backtested performance is not indicative of future results, does not reflect live trading conditions in full, and is not an offer or solicitation to invest. Mitochondria is not yet a SEBI-registered investment manager; this page is informational and intended for discussion with accredited and institutional parties only.
If a trade isn't in the rulebook, it isn't taken. Consistency is the edge, not any single trade.
Position size and drawdown limits are set before a strategy goes live — never adjusted after a loss to "make it back."
Strategy changes are versioned with a dated report, so performance can always be traced back to a specific decision.
Mitochondria is currently founder-led while the strategy and infrastructure are hardened. We're building the team as the track record and regulatory footing grow — not before.
Currently trading proprietary capital while formalizing legal structure and compliance. Outside capital will follow the appropriate registration path, not precede it.